Cargando…

Quantitative assessment of fibrosis-4 score and adverse clinical outcomes in patients with COVID-19

Detalles Bibliográficos
Autores principales:	Tang, Kefu, Wang, Lu, Shen, Lu, He, Lin, Wu, Xi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science China Press 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244247/ https://www.ncbi.nlm.nih.gov/pubmed/35767206 http://dx.doi.org/10.1007/s11427-021-2138-7

Ejemplares similares

Clinical causality assessment for adverse drug reactions
por: Parida, Satyen
Publicado: (2013)

Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome
por: Huang, Xin, et al.
Publicado: (2021)

Orthostatic hypertension and adverse clinical outcomes in adults and older people
por: Damanti, Sarah, et al.
Publicado: (2021)

Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials
por: Ballow, Mark, et al.
Publicado: (2017)

Strategies for a two-step liver fibrosis assessment in clinical practice
por: Vieira Barbosa, Joana, et al.
Publicado: (2021)

Prediction of outcome in perforation peritonitis: Sequential organ function assessment score and inflammatory mediators
por: Arora, Vandna, et al.
Publicado: (2018)

Value of ATRIA risk score and gender in predicting adverse events in patients with myocardial infarction
por: Öncel, Can Ramazan
Publicado: (2018)

Adverse drug reaction and causality assessment scales
por: Zaki, Syed Ahmed
Publicado: (2011)

Low natural killer (NK) cell counts in peripheral blood adversely affect clinical outcome of patients with follicular lymphoma
por: He, L, et al.
Publicado: (2016)

Immune response to vaccination against SARS-CoV-2 in hematopoietic stem cell transplantation and CAR T-cell therapy recipients
por: Wu, Xi, et al.
Publicado: (2022)

Response to the Letter to the Editor Regarding “Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials”
por: Suez, Daniel, et al.
Publicado: (2017)

How to assess cryoballoon ablation‐related adverse events
por: Kataoka, Naoya, et al.
Publicado: (2023)

Comments to Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score
por: Guan, Yong-Song
Publicado: (2014)

COVID‐19 in pregnancy: Risk of adverse neonatal outcomes
por: Mehan, Aman, et al.
Publicado: (2020)

Effectiveness of remote continuous glucose monitoring on adverse outcomes among patients with diabetes complicated with COVID‐19
por: Shen, Yun, et al.
Publicado: (2021)

Assessing risk factors of acute kidney injury and its influence on adverse outcomes after lung transplantation: methodology is important
por: Hu, Bin, et al.
Publicado: (2021)

Assessing the association between dipeptidyl peptidase-4 inhibitors use and celiac disease through drug adverse event reporting
por: Li, Dandan, et al.
Publicado: (2020)

Therapeutic potentials of fasudil in liver fibrosis
por: Xi, Yue, et al.
Publicado: (2021)

Letter to the Editor: Variability but not admission or trends in NEWS2 score predicts clinical outcome in elderly hospitalised patients with COVID-19
por: Sze, Shirley, et al.
Publicado: (2021)

Clinical characteristics and outcome of SARS –CoV-2 infection in patients with cystic fibrosis managed at home
por: Terlizzi, V., et al.
Publicado: (2022)

A clinical risk score of myocardial fibrosis predicts adverse outcomes in aortic stenosis
por: Chin, Calvin W.L., et al.
Publicado: (2016)

Adverse stem cell clones within a single patient’s tumor predict clinical outcome in AML patients
por: Zeller, Christina, et al.
Publicado: (2022)

The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy
por: Buckley, S A, et al.
Publicado: (2015)

An Automated Scoring of Clinical Asthma Score: Proof of Concept and the Future Possibility
por: Al-Omar, Sally, et al.
Publicado: (2021)

Prognostic value of maximum NEWS-2 scores in addition to ISARIC 4C scores for patients admitted to hospital with COVID-19
por: Akbar, Syed, et al.
Publicado: (2022)

A validated clinical-genetic score for assessing the risk of thrombosis in patients with COVID-19 receiving thromboprophylaxis
por: Soria, José Manuel, et al.
Publicado: (2022)

Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)
por: Li, Xiaofei
Publicado: (2021)

Comments on validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease
por: Hong, Jian-Guo, et al.
Publicado: (2022)

Management and outcomes of penile fracture: a retrospective analysis of 62 cases with long-term assessment
por: Tang, Zhuang, et al.
Publicado: (2018)

Thoracic ultrasound: Possible complementary criteria for the assessment of pulmonary fibrosis
por: Trovato, Guglielmo M., et al.
Publicado: (2014)

Clinical Risk Score and COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Muscle mass versus body mass index as predictor of adverse outcome
por: Groothof, Dion, et al.
Publicado: (2021)

Reply to: Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)
por: López-Mendez, Ivan, et al.
Publicado: (2021)

Would the Physicians Eventually Obsolete the Liver Biopsy for the Assessment of Liver Fibrosis?
por: Parsian, Hadi, et al.
Publicado: (2012)

A potentially serious adverse effect of GLP-1 receptor agonists
por: Lu, Jinmiao, et al.
Publicado: (2023)

Assessment of Ganga Hospital Open Injury Severity Score of Limbs
por: Kumar, K. Naveen, et al.
Publicado: (2020)

Clinical implication of coronary artery calcium score
por: Imamura, Teruhiko
Publicado: (2021)

Clinical utility of VExUS score for anaesthesiologists
por: Ahluwalia, Pallavi, et al.
Publicado: (2023)

Residual SYNTAX score II: A combination of the assessment of the revascularization degree and the clinical evaluation after percutaneous coronary intervention
por: Boukhris, Marouane, et al.
Publicado: (2018)

Adverse outcomes in anticoagulated patients undergoing percutaneous left atrial appendage ligation
por: Undas, Anetta
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_79nl65igjdj4pqujdceglpskfl